🌟 Neuraura is thrilled to be named a semi-finalist for the HITLAB Versalie Innovation Challenge! Finalists will be announced soon, only three will move forward for a chance to win a total of $50k in a cash prize. If you'd like to register for the live pitch event on November 21st to see the top innovations in women’s health and menopause—register for free here https://lnkd.in/eWD-ykae We honored to be recognized alongside our friends... Amy Beckley PhD at Proov Rina Carlini, Ph.D. at Healthyher.Life™ and others!
Neuraura
Medical Equipment Manufacturing
Calgary, Alberta 1,865 followers
Neuraura is empowering women's reproductive and metabolic health with a wearable bioelectronic device
About us
PCOS affects more than 10% of women, is the leading cause of female infertility and leads to diabetes in more than half of sufferers before the age of 40. It is one of the most under-researched, under-served and under-funded women’s health conditions. Neuraura is bringing to market the first effective, widely accessible treatment for PCOS as an over-the-counter, affordable device that augments the body's natural processes rather than just masking the symptoms. We are entering the market through an initial application in (pelvic) pain leveraging a predicate regulatory code (NUH) under an FDA 510(k) pathway. Once in market, we will escalate the device claims to the treatment of insulin resistance and other aspects of PCOS, leveraging targeted small-scale clinical studies as well as user data. Longer term, we will develop a premium, reimbursed device for the treatment of pre-diabetes and diabetes.
- Website
-
https://neuraura.com
External link for Neuraura
- Industry
- Medical Equipment Manufacturing
- Company size
- 2-10 employees
- Headquarters
- Calgary, Alberta
- Type
- Privately Held
- Founded
- 2017
- Specialties
- Neurotechnology, wearables, neuromodulation, women's health, metabolic conditions, reproductive health, and femtech
Locations
-
Primary
450 1 St SW
Calgary, Alberta T2P, CA
Employees at Neuraura
-
Claire Dixon
Innovating in Women's Health || Unlocking Bioelectronic Medicine || CEO and co-founder of Neuraura
-
Nandhini Gopal
Venture Builder | Co-Founder @ Femcy (exited)
-
Pierre Wijdenes
Innovation for Health and Social Impact
-
Priyanshi Isapure
Quality Assurance and Regulatory Affairs | Medical Writer | M.Pharm
Updates
-
Our team is thrilled to have been selected as one of the life science startups that will pitch virtually this Thursday for TNT #lifesciences #healthinnovation
The Future of Life Sciences is here! On October 10th, join us for the Life Sciences Virtual Pitch Event powered by API to see some of the most innovative startups in the Life Sciences sector as they pitch their cutting-edge solutions. These companies are tackling major health and technology challenges, and their impact could transform healthcare and beyond. 🔬 Meet companies like: - AssureCKD: Removing barriers to Chronic Kidney Disease testing with affordable, lab-equivalent diagnostics, improving patient outcomes and interventions. - FibroDynamx: Developing anti-scarring therapies to improve quality of life for survivors of deep skin injuries. - Geno10X: Pioneering rapid, non-invasive molecular testing using AI and quantum-dot detection for earlier, more accessible disease screening. AssureCKD | Azor Biotek | Ethoderm Biotechnology | FibroDynamx | Geno10X Biosciences | Headache Sciences Inc. | Klinrisk | MHCombiotic Inc. | Neuraura | RJH Biosciences - Inspired Design, Effective Transfection | SpectraCann These startups drive innovation and could significantly improve patient care, health outcomes, and medical technologies. From early diagnostics and drug discovery to revolutionary therapeutic devices and more, this is your chance to support the next generation of life-changing technologies. 💡 Why attend? - Gain insight into how these emerging companies are tackling unmet needs in healthcare. - Learn from founders at the cutting edge of medical technology, biotech, and AI-driven healthcare solutions. - Be part of a community that supports game-changing life sciences innovation. 📅 October 10th | 12 - 1:30 PM MT | FREE to attend 🔗 Register now: https://bit.ly/LSVirtual24 Let’s rally behind these incredible startups shaping the future of Life Sciences! Stay tuned to our socials this week and next as we further explore and celebrate these epic companies!
-
Our CEO Claire Dixon got the chance to connect with Women+ in MedTeCH this month to share what we're developing with LoOoP. #PCOS #PCOSawareness #healthinnovation #healthequity
📢 To close out PCOS Awareness Month, Women+ in MedTeCH is proud to continue raising awareness about this condition, which affects millions of women yet remains largely underserved. Earlier this month, we published "The Silent Struggle Affecting Millions of Women—What You Need to Know about Polycystic Ovary Syndrome (PCOS)," shedding light on the challenges faced by those with PCOS. 🎤 Now, we’re excited to share an exclusive interview with Claire Dixon, CEO of Neuraura, a startup pioneering a solution for PCOS care. Neuraura’s LoOoP platform combines patented micro-electrodes with a wearable TENS device to provide on-demand, localized stimulation. This innovative approach helps regulate insulin uptake and metabolic functions, addressing key PCOS symptoms. 👇 Check out our interview to learn more about Neuraura’s transformative work and their contributions to women's health. 🌟 #MedTech #WomenAndBeyondInMedteCH #InnovationInHealthTech #PCOSAwareness #WomenInMedTech #HealthInnovation #Empowerment #PCOSSupport #HealthcareCommunity #DEIB
-
What an amazing way to wrap up PCOS Awareness Month! Thank you Women+ in MedTeCH for featuring us and all of the incredible work you do. #PCOS #PCOSawareness #healthinnovation
📢 To close out PCOS Awareness Month, Women+ in MedTeCH is proud to continue raising awareness about this condition, which affects millions of women yet remains largely underserved. Earlier this month, we published "The Silent Struggle Affecting Millions of Women—What You Need to Know about Polycystic Ovary Syndrome (PCOS)," shedding light on the challenges faced by those with PCOS. 🎤 Now, we’re excited to share an exclusive interview with Claire Dixon, CEO of Neuraura, a startup pioneering a solution for PCOS care. Neuraura’s LoOoP platform combines patented micro-electrodes with a wearable TENS device to provide on-demand, localized stimulation. This innovative approach helps regulate insulin uptake and metabolic functions, addressing key PCOS symptoms. 👇 Check out our interview to learn more about Neuraura’s transformative work and their contributions to women's health. 🌟 #MedTech #WomenAndBeyondInMedteCH #InnovationInHealthTech #PCOSAwareness #WomenInMedTech #HealthInnovation #Empowerment #PCOSSupport #HealthcareCommunity #DEIB
LoOoP into the Future of PCOS Treatment: Insights from Neuraura’s CEO
Women+ in MedTeCH on LinkedIn
-
Our CEO Claire Dixon had the opportunity to join other portfolio companies of BoxOne Ventures on a panel yesterday. With thanks to Rebecca Allan, PhD for your gentle questions, the other panellists for your incredible insights and all in attendance for your patience as we stood between you and happy hour! #albertalifescienceweek #healthinnovation
⭐️Trailblazers in Life Sciences! ⭐️ Success stories and strategies by industry leaders in life sciences, curated by API and hosted at Edmonton Unlimited and sponsored by BoxOne Ventures. The talk was moderated by Rebecca Allan, PhD, Investment Manager, Life Sciences at BoxOne Ventures with industry leaders: Michael Wilson, CEO at DrugBank DrugBank is the world's first intelligent and comprehensive drug knowledge platform. Sabina Bruehlmann, CEO at Nimble Science Nimble is the leading global collaborator in delivering actionable intelligence from the small intestine of the Gl tract. Matt Anderson-Baron, CEO at Future Fields Future Fields is a biotechnology company, specializing in producing recombinant proteins for cellular agriculture using their proprietary EntoEngine platform, which leverages fruit flies to create sustainable and scalable biomanufacturing solutions. Claire Dixon, CEO at Neuraura Neuraura is empowering women's reproductive and metabolic health with a wearable bioelectronic device.
-
Our team is absolutely thrilled to have been selected as a semifinalist for the 2024 Women’s Health Tech Challenge. This is even sweeter as we are alongside some of our friends in the the ecosystem including Reya Health, AIMA and Myri Health (Google '24/Techstars '23) (and likely more!). A big thank you to the HITLAB team for this incredible opportunity to elevate innovation in women’s health! Stay tuned for more updates as I move forward in the challenge. Register below for the pitch date on October 4th: https://lnkd.in/eie5uGKC #WHTChallenge2024 #WomensHealthInnovation #TechForGood #InnovationInHealth #Semifinalist
-
Our CEO Claire Dixon is thrilled to be joining API, BoxOne Ventures and our fellow Alberta entrepreneurs for this panel as part of Life Sciences Week 2024 #LifeScienceWeek #healthinnovation
Discover, Connect, and Celebrate with BoxOne Ventures! 🎉 Join us for a dynamic evening with our sponsor, BoxOne Ventures, as part of Life Sciences Week 2024! 🧬 Start by attending the panel, “Trailblazers in Life Sciences: Successes and Strategies from Industry Leaders” at 3:45 PM. Gain insights from industry leaders such as Nimble Science, Neuraura, DrugBank, and Future Fields as they share their success stories and strategies for advancing in the life sciences sector. Reserve your spot here 🎟️👉 https://lu.ma/cju47u86 🧬 After, unwind and network at Happy Hour sponsored by BoxOne from 4:30 PM - 5:30 PM. Enjoy refreshments, engaging conversations, and valuable connections with fellow industry peers! Register for Happy Hour here 🍻👉https://lu.ma/y524br22 Psst… Stick around for Elevator Pitch: the Networking Mixer Gameshow (YEG) to keep the excitement going! Save your seat 👉 https://lu.ma/pdbe0oi1 #LifeSciencesWeek #Networking #Innovation #CalgaryEvents #BoxOneVentures
-
Thank you so much for the shout out from Tech4Eva - The global Femtech accelerator in the context of PCOS Awareness Month #pcos #pcosawareness
Polycystic Ovary Syndrome (PCOS) affects 1 in 10 women of reproductive age, yet it often goes undiagnosed. #PCOS isn't just about irregular periods—it's a complex hormonal disorder that can impact fertility, weight, skin, and mental health. 💡 Know the Signs: Irregular periods, excess hair growth, acne, weight gain, and fatigue. ❤️ Support Each Other: Share your story, raise awareness, and let those with PCOS know they’re not alone. 🔍 Seek Help: Early diagnosis and treatment can help manage symptoms and prevent complications. 🚀Support & Innovation: We're excited to share that 3 startup alumni are focusing on innovative solutions for PCOS management—from web apps and wearable devices to monitoring and screening. Thanks for improving millions of lives: Teal Health Care, viO HealthTech & Neuraura 💜 Here is an interesting article from The Guardian: https://hubs.li/Q02P5_d30 Let's break the silence and support women everywhere. 💪 PCOS Challenge: The National Polycystic Ovary Syndrome Association EPFL Innovation Park Groupe Mutuel #PCOSAwareness #WomensHealth #PCOSMonth #FemTech
-
Our team is incredibly grateful to have been part of the 10th cohort of the Canada-Chicago Mentoring Program (C2MP) at MATTER alongside our Canadian friends PragmaClin Research Inc. (we both love brains!) and Strata Health Canada (another Calgary company). With thanks to the amazing team at MATTER and the incredible support form our Canadian Trade Commissioners. #healthinnovation #healthtech #canadianstartups
📣 Thrilled to have attended the 10th Annual Canada-Chicago Mentoring Program (C2MP) Final Pitch Day at MATTER, hosted by #PointB and the Consulate General of Canada in Chicago | Le Consulat général du Canada à Chicago ! Steven Collens Julien Rosan 🌟 Three exceptional Canadian startups – Neuraura (Claire Dixon), PragmaClin Research Inc. (Bronwyn Bridges), and Strata Health U.S. (Marmmett Horton, MSW, ACM, CMAC) – presented their impressive final pitches, demonstrating their readiness to make a strong impact in the U.S. healthcare landscape. 🚀 🇨🇦🇺🇸 Witnessing the dynamic collaboration between the #Midwest and #Canada ecosystems was truly inspiring. This synergy demonstrates the immense potential for innovation, particularly in health tech, where cross-border partnerships can drive meaningful change. Canada will always hold a special place in our hearts at PACE Healthcare Capital, especially given Julia Monfrini Peev's career at Caisse de dépôt et placement du Québec (CDPQ). 🙏 A special thank you to Dr John Rich from the Rush University Medical Center for his insightful keynote on health equity and innovation. #Startups #C2MP #Innovation #HealthTech #CanadianStartups #Mentorship #Networking #BusinessStrategy #MidwestEcosystem #CanadaEcosystem #CrossBorderInnovation #ChicagoEvents
-
Our team is so incredibly grateful for the support of WIMTACH Centennial College. It was a chance meeting at the MaRS Discovery District Impact Health event last year with Ian Lilley that led to this amazing partnership. #gratitude
Neuraura Biotech Inc., an Alberta based medical equipment company, is on a mission to improve the quality of life of patients dealing with Polycystic ovary syndrome (PCOS). This hormonal condition, often affects the functionality of a woman’s ovaries. While the root cause of this condition is still unknown, people with PCOS can suffer from a range of symptoms including infertility and insulin resistance. Although the condition affects up to one every five women, it is currently one of the many areas of women’s health that is heavily under researched. Addressing this gap in research and treatment is the inspiration behind Neuraura’s development of a wearable bioelectronic device to offer an accessible and personalized treatment to women suffering from pelvic pain and discomfort from #PCOS. To enable users of the device to control, monitor and assess information during the course of their treatment, the company decided to develop a mobile application. WIMTACH was a trusted resource for the Neuraura team for this project. “When we had the opportunity to work with [WIMTACH], we realized there was a part of the development when it comes to software that was a pretty incredible opportunity to tap into,” said Dr. Pierre Wijdenes, Neuraura’s CPO. #projectcollaboration #research Read more: https://lnkd.in/gFz93fX5